{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:54:23Z","timestamp":1771030463513,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Griffith University, School of Pharmacy and Pharmacology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11011-018-0201-y","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T14:30:23Z","timestamp":1520433023000},"page":"1045-1051","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7106-7769","authenticated-orcid":false,"given":"Devinder","family":"Arora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayesh","family":"Mudgal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhavan","family":"Nampoothiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanchari Basu","family":"Mallik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manas","family":"Kinra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailendra","family":"Anoopkumar-Dukie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary D.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chamallamudi Mallikarjuna","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"201_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biochi.2010.09.009","volume":"93","author":"S A\u00efd","year":"2011","unstructured":"A\u00efd S, Bosetti F (2011) Targeting cyclooxygenases-1 and-2 in neuroinflammation: therapeutic implications. Biochimie 93:46\u201351","journal-title":"Biochimie"},{"key":"201_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/ana.1052","volume":"50","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Zhang SM, Hern\u00e1n MA et al (2001) Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women. Ann Neurol 50:56\u201363","journal-title":"Ann Neurol"},{"key":"201_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev.ne.03.030180.000323","volume":"3","author":"RJ Baldessarini","year":"1980","unstructured":"Baldessarini RJ, Tarsy D (1980) Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Annu Rev Neurosci 3:23\u201339","journal-title":"Annu Rev Neurosci"},{"key":"201_CR4","doi-asserted-by":"publisher","first-page":"11521","DOI":"10.1073\/pnas.0502418102","volume":"102","author":"SE Bartlett","year":"2005","unstructured":"Bartlett SE, Enquist J, Hopf FW et al (2005) Dopamine responsiveness is regulated by targeted sorting of D2 receptors. Proc Natl Acad Sci U S A 102:11521\u201311526","journal-title":"Proc Natl Acad Sci U S A"},{"key":"201_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jmb.2011.01.022","volume":"406","author":"DO Borroto-Escuela","year":"2011","unstructured":"Borroto-Escuela DO, Romero-Fernandez W, Tarakanov AO et al (2011) On the existence of a possible A 2A\u2013D 2\u2013\u03b2-Arrestin2 complex: A2A agonist modulation of D2 agonist-induced \u03b2-Arrestin2 recruitment. J Mol Biol 406:687\u2013699","journal-title":"J Mol Biol"},{"key":"201_CR6","doi-asserted-by":"publisher","first-page":"RC 143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","volume":"21","author":"J-F Chen","year":"2001","unstructured":"Chen J-F, Xu K, Petze JP et al (2001) Neuroprotection by caffeine and A (2A) adenosine receptor inactivation in a model of Parkinson\u2019s disease. J Neurosci 21:RC 143","journal-title":"J Neurosci"},{"key":"201_CR7","first-page":"674","volume":"23","author":"B Costall","year":"1973","unstructured":"Costall B, Naylor RJ (1973) Neuroleptic and non-neuroleptic catalepsy. Arzneim Forsc 23:674\u2013683","journal-title":"Arzneim Forsc"},{"key":"201_CR8","doi-asserted-by":"publisher","unstructured":"Dold M, Samare MT, Li C et al (2015) Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD009831.pub2","DOI":"10.1002\/14651858.CD009831.pub2"},{"key":"201_CR9","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/sj.bjp.0703170","volume":"129","author":"M Yacoubi El","year":"2000","unstructured":"El Yacoubi M, Ledent C, Menard JF et al (2000) The stimulant effects of caffeine on locomotor hehaviour in mice are mediated through its blockage of adenosie A2A receptors. Bri J Pharmacol 129:1465\u20131473","journal-title":"Bri J Pharmacol"},{"key":"201_CR10","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1016\/S0028-3908(00)00045-9","volume":"39","author":"BL Fiebich","year":"2000","unstructured":"Fiebich BL, Lieb K, Hull M et al (2000) Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on prostaglandin E2 synthesis in rat microglial cells. Neuropharmacology 39:2205\u20132213","journal-title":"Neuropharmacology"},{"key":"201_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/(SICI)1098-1136(199610)18:2<152::AID-GLIA7>3.0.CO;2-2","volume":"18","author":"BL Fiebich","year":"1996","unstructured":"Fiebich BL, Biber K, Lieb K et al (1996) Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors. GLIA 18:152\u2013160","journal-title":"GLIA"},{"key":"201_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12035-013-8489-4","volume":"49","author":"KA Fujita","year":"2014","unstructured":"Fujita KA, Ostaszewski M, Matsuoka Y et al (2014) Integrating pathways of Parkinson\u2019s disease in a molecular interaction map. Mol Neurobiol 49:88\u2013102","journal-title":"Mol Neurobiol"},{"issue":"Suppl 3","key":"201_CR13","first-page":"16","volume":"61","author":"WM Glazer","year":"2000","unstructured":"Glazer WM (2000) Extrapyramidal side effets, tardive dyskinesia, and the concept of atypicality. J Clin Psychiatry 61(Suppl 3):16\u201321","journal-title":"J Clin Psychiatry"},{"key":"201_CR14","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/npp.2008.116","volume":"34","author":"N Ginovart","year":"2009","unstructured":"Ginovart N, Wilson AA, Hussey D, Houle S, Kapur S (2009) D2-receptor upregulation is dependent upon temporal course of D2-occupancy: a longitudinal [11C]-raclopride PET study in cats. Neuropsychopharmacology 34:662\u2013671","journal-title":"Neuropsychopharmacology"},{"key":"201_CR15","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.foodres.2015.07.027","volume":"76","author":"S Hall","year":"2015","unstructured":"Hall S, Desbrow B, Anoopkumar-Dukie S et al (2015) A review of the bioactivity of coffee, caffeine and key coffee constituents on inflammatory responsed linked to depression. Food Res Int 76:626\u2013636","journal-title":"Food Res Int"},{"key":"201_CR16","doi-asserted-by":"publisher","first-page":"8745","DOI":"10.1021\/acs.jafc.6b03568","volume":"64","author":"S Hall","year":"2016","unstructured":"Hall S, Arora D, Anoopkumar-Dukie S, Grant GD (2016) Effect of coffee in lipopolysaccharide-induced indoleamine 2,3-dioxygenase activation and depressive-like behavior in mice. J Agric Food Chem 64:8745\u20138754","journal-title":"J Agric Food Chem"},{"key":"201_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/oxfordjournals.bmb.a070990","volume":"29","author":"O Hornyckiewicz","year":"1973","unstructured":"Hornyckiewicz O (1973) Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). Br Med Bull 29:172\u2013178","journal-title":"Br Med Bull"},{"key":"201_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0304-3940(00)01371-9","volume":"291","author":"MJ Hurley","year":"2000","unstructured":"Hurley MJ, Mash DC, Jenner P (2000) Adenosine A(2A) receptor mRNA expression in Parkinson\u2019s disease. Neurosci Lett 291:54\u201358","journal-title":"Neurosci Lett"},{"key":"201_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.pbb.2004.07.015","volume":"79","author":"MJ Jackson","year":"2004","unstructured":"Jackson MJ, Al-Barghouthy G, Pearce RK et al (2004) Effect of 5-HT 1B\/D receptor agonist and antagonist administration on motor function in haloperidol and MPTP-treated common marmosets. Pharmacol Biochem Behav 79:391\u2013400","journal-title":"Pharmacol Biochem Behav"},{"key":"201_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0891-5849(90)90131-2","volume":"9","author":"DR Janero","year":"1990","unstructured":"Janero DR (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9:515\u2013540","journal-title":"Free Radic Biol Med"},{"key":"201_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1742-2094-4-2","volume":"4","author":"J Jin","year":"2007","unstructured":"Jin J, Shie FS, Liu I et al (2007) Prostaglandin E 2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated \u03b1-synuclein. J Neuroinflammation 4:2. https:\/\/doi.org\/10.1186\/1742-2094-4-2","journal-title":"J Neuroinflammation"},{"key":"201_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0014-2999(95)00668-0","volume":"295","author":"SH Kafka","year":"1996","unstructured":"Kafka SH, Corbett R (1996) Selective adenosine A2A receptor\/dopamine D2 receptor interactions in animal models of schizophrenia. Eur J Pharmacol 295:147\u2013154","journal-title":"Eur J Pharmacol"},{"key":"201_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nm1362","volume":"12","author":"T Kawano","year":"2006","unstructured":"Kawano T, Anrather J, Zhou P et al (2006) Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 12:225\u2013229","journal-title":"Nat Med"},{"key":"201_CR24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-3565(25)10600-9","volume":"274","author":"T Kikuchi","year":"1995","unstructured":"Kikuchi T, Tottori K, Uwahodo Y et al (1995) 7-{4-[4-(2,3-Dichlorophenyl)-1-Piperazinyl]Butyloxy}-3,4-Dihydro-2(1H)-Quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity. J Pharmacol Exp Ther 274:329\u2013336","journal-title":"J Pharmacol Exp Ther"},{"key":"201_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1471-4159.2001.00607.x","volume":"79","author":"S Latini","year":"2001","unstructured":"Latini S, Pedata F (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 79:463\u2013484","journal-title":"J Neurochem"},{"key":"201_CR26","doi-asserted-by":"publisher","first-page":"7178","DOI":"10.1523\/JNEUROSCI.0008-12.2012","volume":"32","author":"Y Li","year":"2012","unstructured":"Li Y, Roy BD, Wang W et al (2012) Identification of two functionally distinct endosomal recycling pathways for dopamine D2 receptor. J Neurosci 32:7178\u20137190","journal-title":"J Neurosci"},{"key":"201_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/946813","volume":"2012","author":"IV Lima","year":"2012","unstructured":"Lima IV, Bastos LF, Limbor\u00e7o-Filho M, Fiebich BL, de Oliveira AC (2012) Role of prostaglandins in neuroinflammatory and neurodegenerative diseases. Mediat Inflamm 2012:1\u201313. https:\/\/doi.org\/10.1155\/2012\/946813","journal-title":"Mediat Inflamm"},{"key":"201_CR28","doi-asserted-by":"publisher","first-page":"12390","DOI":"10.1523\/JNEUROSCI.1689-07.2007","volume":"27","author":"Y Lizuka","year":"2007","unstructured":"Lizuka Y, Sei Y, Weinberger DR, Straub RE (2007) Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization. J Neurosci 27:12390\u201312395","journal-title":"J Neurosci"},{"key":"201_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s002130050265","volume":"131","author":"G Lucas","year":"1997","unstructured":"Lucas G, Bonhomme N, De Deurwaerd\u00e8re P, Le Moal M, Spampinato U (1997) 8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A\/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release. Psychopharmacology 131:57\u201363","journal-title":"Psychopharmacology"},{"key":"201_CR30","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nsb1196-927","volume":"3","author":"C Luong","year":"1996","unstructured":"Luong C, Miller A, Barnett J et al (1996) Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol 3:927\u2013933","journal-title":"Nat Struct Biol"},{"key":"201_CR31","first-page":"323","volume":"49","author":"D Malec","year":"1996","unstructured":"Malec D (1996) Haloperidol-induced catalepsy is influenced by adenosine receptor antagonists. Pol J Pharmacol 49:323\u2013327","journal-title":"Pol J Pharmacol"},{"key":"201_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1126\/science.504992","volume":"206","author":"JF Marshall","year":"1979","unstructured":"Marshall JF, Berrios N (1979) Movement disorders of aged rats: reversal by dopamine receptor stimulation. Science 206:477\u2013479","journal-title":"Science"},{"key":"201_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1192\/bjp.bp.108.050088","volume":"193","author":"DD Miller","year":"2008","unstructured":"Miller DD, Caroff SN, Davis SM et al (2008) Extrapyramidal side-effects of antipsychotics in a randomised trial. B J Psych 193:279\u2013288","journal-title":"B J Psych"},{"key":"201_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","volume":"582","author":"MS Moron","year":"1979","unstructured":"Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67\u201378","journal-title":"Biochim Biophys Acta"},{"key":"201_CR35","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0028-3908(03)00202-8","volume":"45","author":"RE Moo-Puc","year":"2003","unstructured":"Moo-Puc RE, G\u00f3ngora-Alfaro JL, Alvarez-Cervera FJ et al (2003) Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy. Neuropharmacology 45:493\u2013503","journal-title":"Neuropharmacology"},{"key":"201_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0014-2999(01)01385-1","volume":"430","author":"PS Naidu","year":"2001","unstructured":"Naidu PS, Kulkarni SK (2001) Possible involvment of prostaglandins in haliperidol-induced orofacial dyskinesia in rats. Eur J Pharmacol 430:295\u2013298","journal-title":"Eur J Pharmacol"},{"key":"201_CR37","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0278-5846(01)00289-5","volume":"26","author":"PS Naidu","year":"2002","unstructured":"Naidu PS, Kulkarni SK (2002) Differential effects of cyclooxygenase inhibitors on haloperidol-induced catalepsy. Prog Neuro-Psychopharmacol Biol Psychiatry 26:819\u2013822","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"201_CR38","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","volume":"14","author":"JC O'Connor","year":"2009","unstructured":"O'Connor JC, Lawson MA, Andre A et al (2009) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3 -dioxygenase activation in mice. Mol Psychiatry 14:511\u2013522","journal-title":"Mol Psychiatry"},{"key":"201_CR39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0091-3057(86)90024-9","volume":"25","author":"N Ono","year":"1986","unstructured":"Ono N, Saito R, Abiru T, Kamiya HO, Furukawa T (1986) Possible involvement of prostaglandins in cataleptic behavior in rats. Pharmacol Biochem Behav 25:463\u2013467","journal-title":"Pharmacol Biochem Behav"},{"key":"201_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0952-3278(92)90060-V","volume":"46","author":"N Ono","year":"1992","unstructured":"Ono N, Abiru T, Sugiyama K, Kamiya H (1992) Influences of cyclooxygenase inhibitors on the cataleptic behavior induced by haloperidol in mice. Prostag Leukotr Ess Fatty Acids 46:59\u201363","journal-title":"Prostag Leukotr Ess Fatty Acids"},{"key":"201_CR41","doi-asserted-by":"publisher","first-page":"9293","DOI":"10.1074\/jbc.M113.455816","volume":"288","author":"Y Quan","year":"2013","unstructured":"Quan Y, Jiang J, Dingledine R (2013) EP2 receptor signaling pathways regulate classical activation of microglia. J Biol Chem 288:9293\u20139202","journal-title":"J Biol Chem"},{"key":"201_CR42","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","volume":"283","author":"GW Ross","year":"2000","unstructured":"Ross GW, Abbott RD, Petrovitch H et al (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283:2674\u20132679","journal-title":"JAMA"},{"key":"201_CR43","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/284472a0","volume":"284","author":"PR Sanberg","year":"1980","unstructured":"Sanberg PR (1980) Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors. Nature 284:472\u2013473","journal-title":"Nature"},{"key":"201_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1874620901205010059","volume":"5","author":"RJ Salin-Pascual","year":"2012","unstructured":"Salin-Pascual RJ (2012) Sleep, adenosine and caffeine as tools for the early diagnosis of Parkinson disease. Open Sleep J 5:59\u201366","journal-title":"Open Sleep J"},{"key":"201_CR45","first-page":"113","volume":"8","author":"S Stayte","year":"2014","unstructured":"Stayte S, Vissel B (2014) Advances in non-dopaminergic treatments for Parkinson\u2019s disease. Front Neurosci 8:113","journal-title":"Front Neurosci"},{"key":"201_CR46","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1111\/j.1460-9568.2009.07021.x","volume":"30","author":"Y Tanaka","year":"2009","unstructured":"Tanaka Y, Furuyashiki T, Momiyama T et al (2009) Prostaglandin E receptor EP1 enhances GABA-mediated inhibition of dopaminergic neurons in the substantia nigra pars compacta and regulates dopamine level in the dorsal striatum. Eur J Neurosci 30:2338\u20132346","journal-title":"Eur J Neurosci"},{"key":"201_CR47","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1073\/pnas.0837397100","volume":"29","author":"P Teismann","year":"2003","unstructured":"Teismann P, Tieu K, Choi DK et al (2003) Cyclooxygenase-2 is instrumental in Parkinson\u2019s disease neurodegeneration. Proc Natl Acad Sci 29:5473\u20135478","journal-title":"Proc Natl Acad Sci"},{"key":"201_CR48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/biof.1035","volume":"38","author":"P Teismann","year":"2012","unstructured":"Teismann P (2012) COX-2 in the neurodegenerative process of Parkinson\u2019s disease. Biofactors 38:395\u2013397","journal-title":"Biofactors"},{"key":"201_CR49","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.pbb.2009.02.001","volume":"92","author":"J Trevitt","year":"2009","unstructured":"Trevitt J, Vallance C, Harris A, Goode T (2009) Adenosine antagonists reverse the cataleptic effects of haloperidol: implications for the treatment of Parkinson\u2019s disease. Pharmacol Biochem Behav 92:521\u2013527","journal-title":"Pharmacol Biochem Behav"},{"key":"201_CR50","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.neuropharm.2005.01.009","volume":"48","author":"S Wang","year":"2005","unstructured":"Wang S, Hu LF, Yang Y, Ding JH, Hu G (2005) Studies of ATP-sensitive potassium channels on 6-hydroxydopamine and haloperidol rat models of Parkinson\u2019s disease: implications for treating Parkinson\u2019s disease? Neuropharmacology 48:984\u2013992","journal-title":"Neuropharmacology"},{"key":"201_CR51","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF02244101","volume":"102","author":"F Wanibuchi","year":"1990","unstructured":"Wanibuchi F, Usuda S (1990) Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats. Psychopharmacology 102:339\u2013342","journal-title":"Psychopharmacology"},{"key":"201_CR52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0091-3057(89)90362-6","volume":"34","author":"FB Weihmuller","year":"1989","unstructured":"Weihmuller FB, Hadjiconstantinou M, Bruno JP (1989) Dissociation between biochemical and behavioral recovery in MPTP-treated mice. Pharmacol Biochem Behav 34:113\u2013117","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-018-0201-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0201-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0201-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:48:48Z","timestamp":1751464128000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-018-0201-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["201"],"URL":"https:\/\/doi.org\/10.1007\/s11011-018-0201-y","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,7]]},"assertion":[{"value":"9 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}